Regulation of glycogen synthase kinase-3 in patients with affective disorders.
O'Brien
W Timothy
WT
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Klein
Peter S
PS
D000818:Animals; D018692:Antimanic Agents / Q000494:pharmacology; D001714:Bipolar Disorder / Q000503:physiopathology*; D003865:Major Depressive Disorder / Q000503:physiopathology*; D038362:Glycogen Synthase Kinase 3 / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000071679:Glycogen Synthase Kinase 3 beta; D006801:Humans; D016651:Lithium Carbonate / Q000494:pharmacology; D051379:Mice; D008840:Microfilament Proteins; D017397:Prefrontal Cortex / Q000503:physiopathology; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D016896:Treatment Outcome; D033921:Vesicular Transport Proteins / Q000378:metabolism
D018692:Antimanic Agents; C502451:CCDC88A protein, human; D008840:Microfilament Proteins; D033921:Vesicular Transport Proteins; D016651:Lithium Carbonate; D000071679:Glycogen Synthase Kinase 3 beta; D038362:Glycogen Synthase Kinase 3